Aims and Scope of Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology is a scientific journal for original research pertaining to action of chemicals, drugs, or natural products to animals or humans. The journal covers mechanistic approaches to physiological, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Less
Key Metrics
CiteScore 

7.1
Impact Factor 

< 5
SJR 

Q1Toxicology

SNIP 

0.97
Recommended pre-submission checks
Powered by 

Topics Covered on Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1959 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Toxicology and Applied Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Toxicology and Applied Pharmacology
MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling
- 1 Dec 2026
- Toxicology and Applied Pharmacology
Preoperative serum miR-431-5p as a predictive biomarker for perioperative respiratory adverse events in children undergoing general anesthesia.
- 1 Dec 2026
- Toxicology and applied pharmacology
Shikonin suppresses fibrotic phenotype and oxidative stress in keloid fibroblasts via EGFR-targeted AKT/STAT3/PTGS2 modulation.
- 1 Dec 2026
- Toxicology and applied pharmacology
Levonorgestrel-ethinyl estradiol impairs hepatic lipid clearance to induce hypercholesterolemia via PCSK9-mediated LDLR and CD36 dysregulation.
- 1 Dec 2026
- Toxicology and applied pharmacology
Myocardial senescence as a mechanistic endpoint of arsenic cardiotoxicity: Cysteine-associated p53/p21 activation and reversal by quercetin.
- 1 Dec 2026
- Toxicology and applied pharmacology
The impacts of polystyrene nanoplastics on colorectal cancer: Evidence from integrated network toxicity and in vitro approaches.
- 1 Dec 2026
- Toxicology and applied pharmacology
MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling
- 1 Dec 2026
- Toxicology and Applied Pharmacology
Preoperative serum miR-431-5p as a predictive biomarker for perioperative respiratory adverse events in children undergoing general anesthesia.
- 1 Dec 2026
- Toxicology and applied pharmacology
Shikonin suppresses fibrotic phenotype and oxidative stress in keloid fibroblasts via EGFR-targeted AKT/STAT3/PTGS2 modulation.
- 1 Dec 2026
- Toxicology and applied pharmacology
Levonorgestrel-ethinyl estradiol impairs hepatic lipid clearance to induce hypercholesterolemia via PCSK9-mediated LDLR and CD36 dysregulation.
- 1 Dec 2026
- Toxicology and applied pharmacology
Myocardial senescence as a mechanistic endpoint of arsenic cardiotoxicity: Cysteine-associated p53/p21 activation and reversal by quercetin.
- 1 Dec 2026
- Toxicology and applied pharmacology
The impacts of polystyrene nanoplastics on colorectal cancer: Evidence from integrated network toxicity and in vitro approaches.
- 1 Dec 2026
- Toxicology and applied pharmacology